Opinion

Video

Key Takeaways for Patients With Myelofibrosis

Author(s):

Christine Cooper, RN, BSN,Aaron Gerds, MD, MS

Patients with myelofibrosis should reflect on their personal priorities and quality of life goals, understand the range of available JAK inhibitor treatment options, and openly communicate with their doctor to arrive at a shared decision for managing their disease.

Current Time 0:00
Duration 3:06
Loaded: 5.29%
Stream Type LIVE
Remaining Time 3:06
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    Newsletter

    Stay up to date on cancer updates, research and education

    Subscribe Now!
    Related Videos
    Dosing JAK Inhibitors in Patients With Myelofibrosis
    Dosing JAK Inhibitors in Patients With Myelofibrosis
    Best Approaches to Switching Therapies for a Patient With Myelofibrosis
    Best Approaches to Switching Therapies for a Patient With Myelofibrosis
    Assessing Treatment Response in Patients With Myelofibrosis
    Assessing Treatment Response in Patients With Myelofibrosis
    Adverse Events Seen With JAK Inhibitors for Myelofibrosis
    Adverse Events Seen With JAK Inhibitors for Myelofibrosis
    Clinical Data on the Approved JAK Inhibitors for Treatment of Myelofibrosis
    Clinical Data on the Approved JAK Inhibitors for Treatment of Myelofibrosis
    Management of Anemia in Patients With Myelofibrosis
    Management of Anemia in Patients With Myelofibrosis
    Key Patient Goals for Myelofibrosis Management
    Key Patient Goals for Myelofibrosis Management
    Educational Resources for Patients Diagnosed With Myelofibrosis
    Educational Resources for Patients Diagnosed With Myelofibrosis
    Assessing Risk Level of Patients With Myelofibrosis
    Assessing Risk Level of Patients With Myelofibrosis
    Diagnosing Myelofibrosis
    Diagnosing Myelofibrosis
    Related Content